Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction
Glioblastoma represents the most devastating form of human brain cancer, associated with a very poor survival rate of patients. Unfortunately, treatment options are currently limited and the gold standard pharmacological treatment with the chemotherapeutic drug temozolomide only slightly increases t...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/85a6ad0a3cb8479790113f87b4c61a31 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:85a6ad0a3cb8479790113f87b4c61a31 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:85a6ad0a3cb8479790113f87b4c61a312021-12-01T22:17:40ZGenetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction2234-943X10.3389/fonc.2021.783067https://doaj.org/article/85a6ad0a3cb8479790113f87b4c61a312021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.783067/fullhttps://doaj.org/toc/2234-943XGlioblastoma represents the most devastating form of human brain cancer, associated with a very poor survival rate of patients. Unfortunately, treatment options are currently limited and the gold standard pharmacological treatment with the chemotherapeutic drug temozolomide only slightly increases the survival rate. Experimental studies have shown that the efficiency of temozolomide can be improved by inducing ferroptosis – a recently discovered form of cell death, which is different from apoptosis, necrosis, or necroptosis and, which is characterized by lipid peroxidation and reactive oxygen species accumulation. Ferroptosis can also be activated to improve treatment of malignant stages of neuroblastoma, meningioma, and glioma. Due to their role in cancer treatment, ferroptosis-gene signatures have recently been evaluated for their ability to predict survival of patients. Despite positive effects during chemotherapy, the drugs used to induce ferroptosis – such as erastin and sorafenib – as well as genetic manipulation of key players in ferroptosis – such as the cystine-glutamate exchanger xCT and the glutathione peroxidase GPx4 – also impact neuronal function and cognitive capabilities. In this review, we give an update on ferroptosis in different brain tumors and summarize the impact of ferroptosis on healthy tissues.Marc DahlmannsEduard YakubovJana Katharina DahlmannsFrontiers Media S.A.articleferroptosisneuroblastomaglioblastomaerastinneuronxCTNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
ferroptosis neuroblastoma glioblastoma erastin neuron xCT Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
ferroptosis neuroblastoma glioblastoma erastin neuron xCT Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Marc Dahlmanns Eduard Yakubov Jana Katharina Dahlmanns Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction |
description |
Glioblastoma represents the most devastating form of human brain cancer, associated with a very poor survival rate of patients. Unfortunately, treatment options are currently limited and the gold standard pharmacological treatment with the chemotherapeutic drug temozolomide only slightly increases the survival rate. Experimental studies have shown that the efficiency of temozolomide can be improved by inducing ferroptosis – a recently discovered form of cell death, which is different from apoptosis, necrosis, or necroptosis and, which is characterized by lipid peroxidation and reactive oxygen species accumulation. Ferroptosis can also be activated to improve treatment of malignant stages of neuroblastoma, meningioma, and glioma. Due to their role in cancer treatment, ferroptosis-gene signatures have recently been evaluated for their ability to predict survival of patients. Despite positive effects during chemotherapy, the drugs used to induce ferroptosis – such as erastin and sorafenib – as well as genetic manipulation of key players in ferroptosis – such as the cystine-glutamate exchanger xCT and the glutathione peroxidase GPx4 – also impact neuronal function and cognitive capabilities. In this review, we give an update on ferroptosis in different brain tumors and summarize the impact of ferroptosis on healthy tissues. |
format |
article |
author |
Marc Dahlmanns Eduard Yakubov Jana Katharina Dahlmanns |
author_facet |
Marc Dahlmanns Eduard Yakubov Jana Katharina Dahlmanns |
author_sort |
Marc Dahlmanns |
title |
Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction |
title_short |
Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction |
title_full |
Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction |
title_fullStr |
Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction |
title_full_unstemmed |
Genetic Profiles of Ferroptosis in Malignant Brain Tumors and Off-Target Effects of Ferroptosis Induction |
title_sort |
genetic profiles of ferroptosis in malignant brain tumors and off-target effects of ferroptosis induction |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/85a6ad0a3cb8479790113f87b4c61a31 |
work_keys_str_mv |
AT marcdahlmanns geneticprofilesofferroptosisinmalignantbraintumorsandofftargeteffectsofferroptosisinduction AT eduardyakubov geneticprofilesofferroptosisinmalignantbraintumorsandofftargeteffectsofferroptosisinduction AT janakatharinadahlmanns geneticprofilesofferroptosisinmalignantbraintumorsandofftargeteffectsofferroptosisinduction |
_version_ |
1718404110887157760 |